A Simulation‐Based Assessment of Levetiracetam Concentrations Following Fixed and Weight‐Based Loading Doses: A Meta‐Regression and Pharmacokinetic Modeling Analysis
Open Access
- 6 May 2024
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 64 (9) , 1173-1180
Abstract
Current recommendations for refractory status epilepticus (SE) unresponsive to benzodiazepines suggest a loading dose of levetiracetam (LEV) of 60 mg/kg to a maximum of 4500 mg. LEV therapeutic drug monitoring can help guide therapy and is garnering increasing attention. The objective of this study is to simulate the probability of target attainment (PTA) of fixed dose and weight-based loading doses of LEV with respect to established therapeutic target concentrations. Meta-regression of the current literature was performed to evaluate the relationship between intravenous LEV loading dose and seizure cessation in refractory SE patients. A previously published pharmacokinetic model was used to simulate the PTA capacity of competing single intravenous dosing schemes (fixed vs weight-based dosing) to achieve maximum (C-peak) and 12-h (C-12h) plasma concentrations that exceed 12 mg/L. The meta-regression indicated that dosage was not a statistically significant modulator of seizure control at dosages between 20 and 60 mg/kg. Stochastic simulations showed all dosing schemes achieved plasma C-peak >12 mg/L, but C-12h levels were <12 mg/L in subjects over 60 kg with a fixed dose <= 2000 mg or in subjects <60 kg with a weight-based dose = 90% PTAs across all weights. Using a weight-based loading dose of 40 mg/kg, up to a suggested maximum of 4500 mg, improves the likelihood of achieving a sustained therapeutic drug concentration after the initial LEV dose, whereas fixed <3000 mg may not achieve the desired concentration before maintenance dosing.Keywords
This publication has 31 references indexed in Scilit:
- Population Pharmacokinetics of Levetiracetam: A Systematic ReviewClinical Pharmacokinetics, 2021
- Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage AdjustmentAnnals of Neurology, 2019
- Discontinuation of oral antivirals in chronic hepatitis B: A systematic reviewHepatology, 2016
- A Tutorial on RxODE: Simulating Differential Equation Pharmacometric Models in RCPT: Pharmacometrics & Systems Pharmacology, 2015
- Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot studyEpilepsy Research, 2015
- A Pharmacokinetic Standard for Babies and AdultsJournal of Pharmaceutical Sciences, 2013
- Guidelines for the Evaluation and Management of Status EpilepticusNeurocritical Care, 2012
- Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsyEpilepsy Research, 2012
- Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rulesEpilepsy Research, 2007
- Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjectsClinical Therapeutics, 2006